The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Overview of attention for article published in MMWR: Morbidity & Mortality Weekly Report, November 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
policy: 2 policy sources

twitter: 184 X users
facebook: 3 Facebook pages

Citations

dimensions_citation: 132 Dimensions

Readers on

mendeley: 89 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 3 public wall posts from 3 users.

Newtown Center Pediatrics, 05 Nov 2021

A new MMWR outlines recommendations from the Advisory Committee on Immunization Practices (ACIP) for the Pfizer-BioNTech COVID-19…

MMWR, 05 Nov 2021

After a systematic review of available data, the Advisory Committee on Immunization Practices made an interim recommendation…

CDC, 05 Nov 2021

A new MMWR outlines recommendations from the Advisory Committee on Immunization Practices (ACIP) for the Pfizer-BioNTech COVID-19…